The Pulse
Taiwan accelerator awards top prizes to AI ECG and CT teams
Xindian Zhiyi and DeepRad.AI took the top prizes in the first T+ MedIC Accelerator competition. Fourteen teams competed across incubation and startup tracks.

An AI-assisted electrocardiogram tool and a preventive screening platform using low-dose chest CT scans have won the top prizes in the first competition of a Taiwanese medical innovation accelerator. The T+ MedIC Accelerator named the winners from 14 finalist teams after its first final round, held Nov. 2.
Xindian Zhiyi, a Tri-Service General Hospital team developing the ECG tool, won the incubation track. DeepRad.AI took first place in the startup acceleration track with its screening platform.
Two routes into the competition
MacKay Memorial Hospital and Tri-Service General Hospital founded the accelerator in partnership with the Industrial Technology Research Institute, or ITRI. The final competition and awards ceremony took place on Nov. 2 at MacKay in Taipei, with seven teams pitching in each track.
The incubation track is open to unincorporated teams whose core members work at the organizing hospitals or their affiliated institutions. The startup acceleration track accepts startups founded within the past eight years and in-house biomedical ventures of larger organizations.
Finalists presented projects covering clinical decision support, nursing workflows, health monitoring and mobility assistance. The program combines a selection process with mentoring intended to help medical startups validate technologies and move them toward clinical use.
ECG and bone-age tools recognized
Xindian Zhiyi uses AI to help analyze and interpret electrocardiograms, with the aim of improving disease detection and clinical decision-making. Two teams shared second place in the incubation track, including MacKay's Department of Digital Medicine for an AI system that interprets bone age.
The bone-age system compares cases with images from real patients and has been used clinically more than 1,500 times, according to the accelerator. The other second-place team, from Tri-Service, developed a connector for chemotherapy delivered through a urinary catheter, designed to reduce health care workers' exposure to the drugs and make the procedure safer to handle.
The remaining incubation finalists were SonoMedic, an AI smart nursing cart control system, a MacKay sepsis team and OR-LLM.
Screening projects take startup prizes
DeepRad.AI won the startup track with a multimodal preventive screening platform. It combines low-dose chest CT with AI to assess lung, cardiovascular and bone health risks at the same time, according to the accelerator.
Second place went to FUTUREMED PreCancer, which applies liquid biopsy to explore ultra-early cancer screening. Tri-Service General Hospital's Digital Medical Center placed third for an AI-enhanced chest X-ray tool intended to screen lung function non-invasively and support clinical decisions.
The organizers said the center's development record is tied to three software-as-a-medical-device licenses from Taiwan's Food and Drug Administration. The other startup finalists were exebrain, GaitRich, Ebot Robotics and Rest Guard.
Mentoring and hospital support
Under the program timeline, winning teams enter a mentoring phase starting Nov. 3. Competition rules also allow the top three teams in each track to receive proposals for hospital collaboration and additional accelerator support.
The organizers plan to invite more medical institutions to join, with the aim of broadening cooperation across Taiwan's public and private health systems. ITRI said the program combines hospital expertise with its experience connecting teams to industry and supporting commercialization, including help with validation and product-development planning.
MacKay deputy superintendent Dr. Hung Ta-chuan said the accelerator's goals include integrating resources, bringing technical advances into clinical practice and building patent strategies for commercialization. Tri-Service deputy superintendent Dr. Wu Chia-chao said the two hospitals' large clinical caseloads and expertise, combined through cross-hospital collaboration, can speed up the validation and real-world adoption of new technologies.
Source
Related stories
- Taiwan Plans Criminal Charges for Restricted AI Server Exports
- Appier reports operating income more than doubled, raises forecast
- CHIME says 93.2% of surveyed health organizations use AI
- Digi Power X says quarterly AI revenue rose more than 400%
- Dyania and Nvidia team up on clinical AI inside hospital networks